CD4+CD25+ Tregs and NKT cells:: regulators regulating regulators

被引:152
作者
La Cava, Antonio [1 ]
Van Kaer, Luc
Fu-Dong-Shi
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[2] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA
[3] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA
关键词
D O I
10.1016/j.it.2006.05.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+)CD25(+) regulatory T cells (Tregs) and natural killer T (NKT) cells are two populations of T lymphocytes that can independently regulate adaptive and innate immune responses. Although most studies have investigated the regulatory properties of these T-cell subsets independently of each other, recent reports have provided evidence for cross-talk between Tregs and NKT cells, and, consequently, the immunoregulatory networks are seen in a new perspective. Activated NKT cells seem to modulate quantitatively and qualitatively Treg function through IL-2-dependent mechanisms, whereas Tregs can suppress the proliferation, cytokine release and cytotoxic activity of NKT cells by cell-contact-dependent mechanisms. Importantly, Tregs and NKT cells share crucial signaling pathways that could be responsible for their concerted responses. The advances in our understanding of the interactions between distinct subsets of regulatory T cells in autoimmunity might unveil new methods for harnessing these cells with immunotherapeutic properties.
引用
收藏
页码:322 / 327
页数:6
相关论文
共 70 条
  • [1] Tolerance to nickel: Oral nickel administration induces a high frequency of anergic T cells with persistent suppressor activity
    Artik, S
    Haarhuis, K
    Wu, XZ
    Begerow, J
    Gleichmann, E
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (12) : 6794 - 6803
  • [2] Azuma T, 2003, CANCER RES, V63, P4516
  • [3] Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis
    Balandina, A
    Lécart, S
    Dartevelle, P
    Saoudi, A
    Berrih-Aknin, S
    [J]. BLOOD, 2005, 105 (02) : 735 - 741
  • [4] NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic β cells
    Beaudoin, L
    Laloux, V
    Novak, J
    Lucas, B
    Lehuen, A
    [J]. IMMUNITY, 2002, 17 (06) : 725 - 736
  • [5] Therapeutic vaccination using CD4+ CD25+ antigen-specific regulatory T cells
    Bluestone, JA
    Tang, QZ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 : 14622 - 14626
  • [6] The two NF-κB activation pathways and their role in innate and adaptive immunity
    Bonizzi, G
    Karin, M
    [J]. TRENDS IN IMMUNOLOGY, 2004, 25 (06) : 280 - 288
  • [7] Requirement for V(alpha)14 NKT cells in IL-12-mediated rejection of tumors
    Cui, JQ
    Shin, T
    Kawano, T
    Sato, H
    Kondo, E
    Toura, I
    Kaneko, Y
    Koseki, H
    Kanno, M
    Taniguchi, M
    [J]. SCIENCE, 1997, 278 (5343) : 1623 - 1626
  • [8] Requirement for CARMA1 in antigen receptor-induced NF-κB activation and lymphocyte proliferation
    Egawa, T
    Albrecht, B
    Favier, B
    Sunshine, MJ
    Mirchandani, K
    O'Brien, W
    Thome, M
    Littman, DR
    [J]. CURRENT BIOLOGY, 2003, 13 (14) : 1252 - 1258
  • [9] NIK-dependent RelB activation defines a unique signaling pathway for the development of Vα14i NKT cells
    Elewaut, D
    Shaikh, RB
    Hammond, KJL
    De Winter, H
    Leishman, AJ
    Sidobre, S
    Turovskaya, O
    Prigozy, TI
    Ma, L
    Banks, TA
    Lo, D
    Ware, CF
    Cheroutre, H
    Kronenberg, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) : 1623 - 1633
  • [10] Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state
    Fisson, S
    Darrasse-Jèze, G
    Litvinova, E
    Septier, F
    Klatzmann, D
    Liblau, R
    Salomon, BL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (05) : 737 - 746